Why couldn't the FDA put all the data together and
Post# of 145707
The saftey is the same for both.
The manufacturing is the same for both.
And now they have all of CYDY's data from the mono patients. Why would they want to do double the work later? Am I missing something?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)